(Q44572163)

4 December 2017

title

Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and usefulness of genotype testing (English)

1 reference

4 December 2017

Shiro Ibe

1

1 reference

4 December 2017

Naoe Hotta

2

1 reference

4 December 2017

Uta Takeo

3

1 reference

4 December 2017

Yukio Tawada

4

1 reference

4 December 2017

Naoto Mamiya

5

1 reference

4 December 2017

Katsuo Yamanaka

6

1 reference

4 December 2017

Makoto Utsumi

7

1 reference

4 December 2017

Tsuguhiro Kaneda

8

1 reference

4 December 2017

language of work or name

1 reference

1 January 2003

1 reference

Microbiology and Immunology

4 December 2017

published in

1 reference

4 December 2017

volume

47

1 reference

4 December 2017

issue

7

1 reference

4 December 2017

page(s)

499-505

1 reference

HIV protease and reverse transcriptase variation and therapy outcome in antiretroviral-naive individuals from a large North American cohort.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

HIV-1 drug resistance in newly infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

Selection of human immunodeficiency virus type 1 variants with an insertion mutation in the p6(gag) and p6(pol) genes under highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

Antiretroviral-drug resistance among patients recently infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2003.TB03411.X

10.1111/J.1348-0421.2003.TB03411.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference